Index trend and stocks in action July 19, 2018
Index trend and stocks in action July 19, 2018

Index trend and stocks in action July 19, 2018

Karan Dsij Article rating: 5.0

Going ahead, Nifty has crucial support in the range 10,900-10,930, and if it holds above this zone, the short term structure will continue to be positive. Stocks in news: MCX, DFM Foods, JSW Steel, Cadila Healthcare, Poddar Housing and Development and Indian Overseas Bank. 

Markets may see positive opening on encouraging cues from Asian peers
Markets may see positive opening on encouraging cues from Asian peers

Markets may see positive opening on encouraging cues from Asian peers

Karan Dsij Article rating: 5.0

Indian shares are expected to open positive, tracking slightly optimistic cues from the Asian peers. The bullish trend in SGX Nifty, which was trading at 11,012, up by 30 points, indicated that domestic bourses may witness a positive opening. ABB India, Bajaj Finance, Bajaj Finserv, DB Corp, RBL Bank, Kotak Mahindra Bank, Sterlite Technologies are set to declare their results.  

JM Financial post stable numbers
JM Financial post stable numbers

JM Financial post stable numbers

Rohan Takalkar Article rating: No rating

JM financial reported stable consolidated performance for the quarter ended Q1FY19. The bank's revenue from investment banking declined over the same period previous year.

The lone warrior among the large-cap category
The lone warrior among the large-cap category

The lone warrior among the large-cap category

Nikhil Desai Article rating: 3.8

The year of 2017 was the year of wealth creation for the investors, but the year 2018 is checking the patience of investors. Since the last six months, the markets have been witnessing a roller-coaster ride with weak global cues and other macroeconomic traps.

Sun Pharma rises as USFDA approves Infugem injection
Sun Pharma rises as USFDA approves Infugem injection

Sun Pharma rises as USFDA approves Infugem injection

Sanket Dewarkar Article rating: 5.0

Sun Pharmaceutical Industries including its subsidiaries and/or associate companies have received approval from the US Food and Drug Administration (USFDA) for Infugem (gemcitabine in 0.9 per cent sodium chloride injection) 10 mg/mL, for intravenous use in a ready-to-administer (RTA) bag.

Deciphering the rise in MF AUM
Deciphering the rise in MF AUM

Deciphering the rise in MF AUM

Shashikant Singh Article rating: 5.0

Domestic MF AUM has witnessed a humongous increase in asset under management in the last few years. Read on to find who contributed for such rise.

RSS
First32773278327932803282328432853286Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR